Thermo Fisher Scientific has agreed to buy Life Technologies for $13.6 billion, reports Bloomberg News. Thermo Fisher will be paying $76 a share for the company, adds Daily Scan sister publication GenomeWeb Daily News.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: The sea anemone is sequenced, a team describes a CRISPR/Cas9-based approach to label specific sites in the genome, and more.
In a short video, CNN introduces viewers to a fecal transplant poop donor and explains how the treatments are made.
Researchers are testing the use of transgenically altered diamondback moths as an alternative to pesticides in controlling the bugs.
Two recent papers published in Science and Nature Medicine describe work that may result in a universal vaccine for the flu.